Skip to main content
. Author manuscript; available in PMC: 2020 Oct 5.
Published in final edited form as: HPB (Oxford). 2018 Aug 4;21(3):345–351. doi: 10.1016/j.hpb.2018.07.014

Table 4:

Propensity score matched comparison of perioperative outcomes

West (n=45) East (n=45)
Age, median (IQR) 69 (60–76) 66 (64–73) 0.824
Male gender, n 28 34 0.255
ASA score, n
1
2
3

8
33
4

6
33
6
0.710
Jaundice at presentation, n 17 15 0.826
Directly preoperative bilirubin, μmol/L, median (IQR) 12 (9–21) 15 (10–22) 0.445
Preoperative biliary drainage, n
None
Percutaneous
Endoscopic
Both

11
8
14
12

9
2
32
2
< 0.001
Preoperative cholangitis, n 14 17 0.658
Future live remnant share, %, median (IQR) 64 (40–76) 60 (48–69) 0.939
Portal vein embolization, n 6 8 0.772
Type of resection, n
Left hemihepatectomy
Extended left hemihepatectomy
Right hemihepatectomy
Extended right hemihepatectomy

26
3
13
3

27
2
13
3
0.974
Portal vein reconstruction, n 13 12 1.000
Operative time, min, median (IQR) 447 (394–564) 639 (553–749) < 0.001
Estimated blood loss, mL, median (IQR) 1280 (500–2422) 1610 (1310–2470) 0.013
Margin, R0, n 29 37 0.094
Final pathology, n
Perihilar cholangiocarcinoma
IPNB
Benign

41
3
1

45
-
-
0.123
Morbidity, Dindo grade III or higher, n 25 19 0.292
Liver failure, ISGLS grade B/C, n 7 10 0.591
Biliary leakage, ISGLS grade B/C, n 17 6 0.015
Hemorrhage, ISGLS grade B/C, n 5 0.714
90-day mortality, n 3 4 1.000